Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia

Tandler, Claudia; Schmidt, Moritz; Heitmann, Jonas S.; Hierold, Julia; Schmidt, Jonas; Schneider, Pascal; Doerfel, Daniela; Walz, Juliane; Salih, Helmut R.

dc.contributor.author	Tandler, Claudia
dc.contributor.author	Schmidt, Moritz
dc.contributor.author	Heitmann, Jonas S.
dc.contributor.author	Hierold, Julia
dc.contributor.author	Schmidt, Jonas
dc.contributor.author	Dörfel, Daniela
dc.contributor.author	Walz, Juliane S.
dc.contributor.author	Salih, Helmut R.
dc.date.accessioned	2021-06-11T10:37:35Z
dc.date.available	2021-06-11T10:37:35Z
dc.date.issued	2020
dc.identifier.issn	2072-6694
dc.identifier.uri	http://hdl.handle.net/10900/116270
dc.language.iso	en	en
dc.publisher	Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/cancers12102725
dc.subject.ddc	610	de_DE
dc.title	Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210304112512_01205
utue.personen.roh	Tandler, Claudia
utue.personen.roh	Schmidt, Moritz
utue.personen.roh	Heitmann, Jonas S.
utue.personen.roh	Hierold, Julia
utue.personen.roh	Schmidt, Jonas
utue.personen.roh	Schneider, Pascal
utue.personen.roh	Doerfel, Daniela
utue.personen.roh	Walz, Juliane
utue.personen.roh	Salih, Helmut R.
dcterms.isPartOf.ZSTitelID	Cancers	de_DE
dcterms.isPartOf.ZS-Issue	Article 2725	de_DE
dcterms.isPartOf.ZS-Volume	12	de_DE
utue.fakultaet	04 Medizinische Fakultät
utue.fakultaet	Sonstige